Login / Signup

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.

Jeffrey SzerDaniel WeisdorfSergio QuerolLydia FoekenAlejandro Madrigal
Published in: Bone marrow transplantation (2020)
Keyphrases
  • hematopoietic stem cell
  • coronavirus disease
  • sars cov
  • oxidative stress
  • palliative care
  • respiratory syndrome coronavirus